drugset / Trial / NCT00633568

Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung Cancer

NCT00633568 ↗

Phase 3 Terminated 125 enrolled European Lung Cancer Working Party
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the present trial is to assess if induction concurrent chemoradiotherapy followed by consolidation chemotherapy will improve survival in comparison with the same chemotherapy given as induction followed by consolidation concurrent chemoradiotherapy.

Timeline

Start
2007-01
Primary completion
2014-12
Completion
2015-02

Outcome

Outcome not reported

Stopped (Enrollment): “Slow recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cisplatin Other / unclassified 20 mg/m2 —
Comparator Cisplatin Other / unclassified 60 mg/m2 —
Comparator Docetaxel Small molecule 20 mg/m2 —
Comparator Docetaxel Small molecule 75 mg/m2 —